IMMP
Immutep Ltd ADR
NASDAQ: IMMP · HEALTHCARE · BIOTECHNOLOGY
$0.48
-2.01% today
Updated 2026-04-29
Market cap
$77.30M
P/E ratio
—
P/S ratio
9.76x
EPS (TTM)
$-0.41
Dividend yield
—
52W range
$0 – $3
Volume
18.7M
Immutep Ltd ADR (IMMP) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-764.00%
ROE
-61.90%
ROA
-32.10%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2008 | — | $-1.89M | — | — | — |
| 2009 | — | $-2.95M | — | — | — |
| 2010 | $523734.00 | $-12.16M | 100.00% | -1,506.55% | -2,321.57% |
| 2011 | — | $-21.08M | — | — | — |
| 2012 | $1.52M | $-19.94M | 92.29% | -1,213.95% | -1,311.89% |
| 2013 | $4.01M | $-15.23M | 76.56% | -377.12% | -380.13% |
| 2014 | $3.14M | $-13.34M | 77.28% | -424.51% | -424.94% |
| 2015 | $2.09M | $-32.15M | 89.53% | -665.30% | -1,536.25% |
| 2016 | $175052.00 | $-62.02M | -3,932.82% | -35,117.79% | -35,426.72% |
| 2017 | $4.22M | $-9.37M | 59.69% | -221.55% | -221.89% |
| 2018 | $2.63M | $-12.75M | -279.77% | -444.55% | -484.55% |
| 2019 | $139782.00 | $-16.27M | -11,769.34% | -14,606.55% | -11,640.01% |
| 2020 | $7.49M | $-13.47M | -200.18% | -213.97% | -179.90% |
| 2021 | $3.86M | $-29.90M | -346.22% | -820.05% | -774.12% |
| 2022 | $170369.00 | $-32.21M | -1,111.18% | -19,920.03% | -18,906.51% |
| 2023 | $3.51M | $-39.90M | 41.19% | -2,216.05% | -1,138.04% |
| 2024 | $3.84M | $-42.72M | -981.42% | -2,293.26% | -1,111.87% |
| 2025 | $5.04M | $-61.43M | -1,117.55% | -2,506.49% | -1,218.02% |